Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-073031
Filing Date
2023-12-26
Accepted
2023-12-26 16:10:05
Documents
1
Period of Report
2023-12-21

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3996
  Complete submission text file 0000950170-23-073031.txt   5446
Mailing Address 11804 NORTH CREEK PARKWAY S BOTHELL WA 98011
Business Address
Bucher James B (Reporting) CIK: 0001664928 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 231513428

Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)